Primary Ovarian Cancer Establishment Media (Ince OCMI-e) (Liquid)

Print

Cat# 506389-500ml

Size : 500ml

Contact local distributor :

Phone : +1 850 650 7790

Brand : US Biological

Request more information

Contact local distributor :

Phone : +1 850 650 7790

506389 Primary Ovarian Cancer Establishment Media (Ince OCMI-e) (Liquid)

Clone Type

Polyclonal

Shipping Temp

Blue Ice

Storage Temp

4°C Do Not Freeze/-20°C

Primary Ovarian Cancer Establishment Media (Ince)||Tan A. Ince, MD, PhD - Fighting Cancer by Keeping Cancer Cells Alive ...|https://www.scientia.global/tan-ince-md-phd-fighting-cancer-keeping-cancer-cells-alive/||Feb 12, 2017 - Professor Ince was a visiting clinical scientist at the Massachusetts Institute of Technology from 2000 to 2007, where he developed a new cell culture nutrient medium that is now widely used to grow human breast and ovary cells.||Customer supplied:|To be supplemented with 2% fetal bovine serum to media|To be supplemented with Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media.||Appearance:|Red to orange, clear, complete||OCMI-e Bullet 1 Included (506389B, Colorless): |Supplied as a liquid. Thaw, vortex, spin down and add whole vial to 506389. ||OCMI-e Bullet 2 Included (506389C, Pink): |Supplied as a liquid. Thaw, vortex, spin down and add whole vial to 506389. ||Storage (506389B, 506389C):|Liquid is stable at -20°C. ||Storage and Stability (w/o supplements):|Store at 4°C. Do not freeze. Light sensitive, store in the dark. Stable for 6 months w/o supplements.||Storage and Stability (w/ supplements):|Complete media with supplements is stable for 6 weeks at 4°C. Do Not Freeze. Light sensitive, store in the dark.||Country of Origin|United States||Customer supplied:|To be supplemented with 2% fetal bovine serum to media|To be supplemented with Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media.||Important Note: |Cholera toxin is NOT included in the liquid media nor the bullet. Shipping regulations have made it increasingly difficult to ship. Please procure from your local supplier. Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media.||Licensed by TumorGenesisTM. Manufactured for research use by US Biological.

Applications

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. ||Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.

References

1. Tan A. Ince, MD, PhD - Fighting Cancer by Keeping Cancer Cells Alive .https://www.scientia.global/tan-ince-md-phd-fighting-cancer-keeping-cancer-cells-alive. 2. AE Witt, CW Lee, TI Lee, DI Azzam, B Wang, C Caslini, F Petrocca, J Grosso, M Jones, EB Cohick, AB Gropper, C Wahlestedt, AL Richardson, R Shiekhattar, RA Young and TA Ince, Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer, Oncogene, 2016. DOI: 10.1038/ onc.2016.337. 3. A Thakkar, B Wang, M Picon-Ruiz, P Buchwald and TA Ince, Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer, Breast Cancer Res. Treat., 2016, 157, 77–90. 4. TA Ince, AD Sousa, MA Jones, JC Harrell, ES Agoston, M Krohn, LM Selfors, W Liu, K Chen, M Yong, P Buchwald, B Wang, KS Hale, E Cohick, P Sergent, A Witt, Z Kozhekbaeva, S Gao, AT Agoston, MA Merritt, R Foster, BR Rueda, CP Crum, JS Brugge, GB Mills, Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours, Nat. Commun., 2015, 6, 7419. 5. S Santagata, A Thakkar, A Ergonul, B Wang, T Woo, R Hu, JC Harrell, G McNamara, M Schwede, AC Culhane, D Kindelberger, S Rodig, A Richardson, SJ Schnitt, RM Tamimi and TA Ince, Taxonomy of breast cancer based on normal cell phenotype predicts outcome, J. Clin. Invest., 2014, 124, 859–870.

You might also be interested by the following products:

Cat#

Description

Cond.

Price Bef. VAT

LL-100B

Cholera Toxin (Azide Free)

1mg